{"name":"Caxton Advantage Life Sciences Fund","permalink":"caxton-advantage-life-sciences-fund","crunchbase_url":"http://www.crunchbase.com/financial-organization/caxton-advantage-life-sciences-fund","homepage_url":null,"blog_url":null,"blog_feed_url":null,"twitter_username":null,"phone_number":null,"description":null,"email_address":null,"number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":null,"created_at":"Sun Apr 12 19:31:08 UTC 2009","updated_at":"Tue Sep 01 07:29:19 UTC 2009","overview":"<p>Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.</p>","image":null,"offices":[{"description":"","address1":"","address2":"","zip_code":"","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.pehub.com/36508/vcs-pipe-435-million-to-sunesis-pharma/","source_description":"VCs PIPE $43.5 Million to Sunesis Pharma","raised_amount":43500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Sunesis Pharmaceuticals","permalink":"sunesis-pharmaceuticals","image":{"available_sizes":[[[133,75],"assets/images/resized/0004/0936/40936v1-max-150x150.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-250x250.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.basmedical.com/investor20071220.html","source_description":"Corthera Closes $23 Million Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":20,"company":{"name":"Corthera","permalink":"corthera","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/2839/52839v1-max-150x150.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-250x250.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020091217e5ch000jh&r=Rss&s=DJFVW","source_description":"Regado Biosciences Stays Patient, Looks To Europe With New $40M  ","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":17,"company":{"name":"Regado Biosciences","permalink":"regado-biosciences","image":{"available_sizes":[[[150,23],"assets/images/resized/0007/0256/70256v1-max-150x150.jpg"],[[250,39],"assets/images/resized/0007/0256/70256v1-max-250x250.jpg"],[[352,56],"assets/images/resized/0007/0256/70256v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.siliconindia.com/shownews/Gemin_X_Pharmaceuticals_closes_38_Mn_Series_C_financing-nid-43319.html","source_description":"Gemin X Pharmaceuticals closes $38 Mn Series C financing","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":3,"company":{"name":"Gemin X Pharmaceuticals","permalink":"gemin-x-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/9935/79935v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0007/9935/79935v1-max-250x250.jpg"],[[263,72],"assets/images/resized/0007/9935/79935v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/gemin-x-books-16m-series-d-it-pursues-phiib-cancer-trial/2010-04-20","source_description":"Gemin X books $16M Series D as it pursues PhIIb cancer trial  Read more: http://www.fiercebiotech.com/story/gemin-x-books-16m-series-d-it-pursues-phiib-cancer-trial/2010-04-20#ixzz0lfnwA8xR","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":20,"company":{"name":"Gemin X Pharmaceuticals","permalink":"gemin-x-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/9935/79935v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0007/9935/79935v1-max-250x250.jpg"],[[263,72],"assets/images/resized/0007/9935/79935v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/gemin-x-pharmaceuticals-inc-series-e-8m/","source_description":"Gemin X Pharmaceuticals, Inc.: Series E $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":24,"company":{"name":"Gemin X Pharmaceuticals","permalink":"gemin-x-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/9935/79935v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0007/9935/79935v1-max-250x250.jpg"],[[263,72],"assets/images/resized/0007/9935/79935v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}